Verona Pharma PLC American Depositary Share (VRNA) Gains But Lags Market: What You Should Know
In the latest trading session, Verona Pharma PLC American Depositary Share (VRNA) closed at $21.43, marking a +0.4% move from the previous day. This change lagged the S&P 500's 0.53% gain on the day. Meanwhile, the Dow gained 0.33%, and the Nasdaq, a tech-heavy index, lost 5.2%.
Coming into today, shares of the company had lost 8.27% in the past month. In that same time, the Medical sector lost 2.5%, while the S&P 500 gained 0.67%.
Wall Street will be looking for positivity from Verona Pharma PLC American Depositary Share as it approaches its next earnings report date. This is expected to be March 7, 2023. In that report, analysts expect Verona Pharma PLC American Depositary Share to post earnings of -$0.22 per share. This would mark year-over-year growth of 45%.
Investors might also notice recent changes to analyst estimates for Verona Pharma PLC American Depositary Share. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Verona Pharma PLC American Depositary Share is currently sporting a Zacks Rank of #3 (Hold).
The Medical - Biomedical and Genetics industry is part of the Medical sector. This group has a Zacks Industry Rank of 91, putting it in the top 37% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Verona Pharma PLC American Depositary Share (VRNA) : Free Stock Analysis Report
